Will 2026 bring real drug price relief? The 340B Program expands, offering up to 50% lower costs for clinics and patients. See what's next.
·
·
8 min read
75% of nations lack CRISPR gene-editing laws. This regulatory gap creates risk and opportunity. See why it matters & what's next for global rules.
·
·
7 min read
Rural areas face a healthcare access crisis. Why 130 hospitals may close by 2026, impacting 20% of the US population, and what comes next.
·
·
7 min read
A $10.5 billion funding gap threatens global health preparedness. Learn why current systems leave us vulnerable and what needs to change.
·
·
6 min read
2026 Medicare Part D premiums are changing. See how the $2,000 out-of-pocket cap & IRMAA will affect your drug costs and budget.
·
·
4 min read
340B reform in 2026: See why debates over drug costs and 14,000 providers matter. What changes could impact patient access and policy?
·
·
9 min read
Understand how drug rebates inflate costs. Learn what 2026 reforms aim to do and why PBM transparency matters for patients.
·
·
7 min read
Copay cards boost drug access, especially for chronic conditions. See how they increase patient adherence and what regulatory changes mean for 2025.
·
·
7 min read
After COVID-19, how can global health systems prevent future crises? Learn 5 key strategies, like WHO's surveillance, for resilience by 2026.
·
·
7 min read
The UK's 2027/28 flu strategy prioritizes advanced quadrivalent vaccines. Learn why this shift matters for public immunity and who like CSL Seqirus is invol
·
·
7 min read